1-20 of 246
geographic area
Close
Sort by
Journal Articles

Utilization and Early Discontinuation of First-Line Ibrutinib for Patients with Chronic Lymphocytic Leukemia Treated in the Community Oncology Setting in the United States

Scott F. Huntington, MD MPH, Pamela R. Soulos, Paul M. Barr, MD, Ryan Jacobs, MD, Frederick Lansigan, MD, Oreofe O. Odejide, MD MPH, Lee S. Schwartzberg, MD, Amy J. Davidoff, PhD MS, Cary P Gross, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 797.
https://doi.org/10.1182/blood-2019-122054
Published: 2019
Journal Articles

A Population-Based Analysis of Predictors of Survival and Trends in Outcomes of Elderly Patients with Multiple Myeloma (MM)

Vivek Kumar, MD, M.B.,B.S., Meghna Ailawadhi, MD, Mays F Abdulazeez, MBBS, Suman Biswas, MD, Sri Lekha Bodepudi, Leyla Bojanini, MD, Vivek Roy, MD, Taimur Sher, MD, Victoria R. Alegria, Rami Manochakian, MD, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4779.
https://doi.org/10.1182/blood-2019-125156
Published: 2019
Journal Articles

ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

Jeff P. Sharman, MD, Versha Banerji, MD, Laura Maria Fogliatto, MD PhD, Yair Herishanu, MD, Talha Munir, MD, Renata Walewska, George Follows, Karin Karlsson, MD, Paolo Ghia, MD PhD, Gillian Corbett, Patricia Walker, MBBS, Miklos Egyed, Wojciech Jurczak, MD PhD, Gilles Salles, MD PhD, Ann Janssens, Florence Cymbalista, MD PhD, William G. Wierda, MD PhD, Steven Coutre, MD, John M. Pagel, MD PhD DSc, Alan Skarbnik, MD, Manali Kamdar, MD, Jennifer Woyach, MD, Raquel Izumi, PhD, Veerendra Munugalavadla, PhD, Priti Patel, MD, Min Hui Wang, PhD, Sofia Wong, John C. Byrd, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 31.
https://doi.org/10.1182/blood-2019-128404
Published: 2019
Journal Articles

Predictors of Transfer to Different Facility at Discharge in Patients Admitted with Hematologic Malignancy: A Nationwide Inpatient Sample (NIS) Database Analysis

Sunny R K Singh, MD, Sindhu Malapati, MD, Rohit Kumar, MD, Olekdandra Lupak, MD, Philip Kuriakose, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2132.
https://doi.org/10.1182/blood-2019-127604
Published: 2019
Journal Articles

Sociodemographic and Clinical Characteristics Associated with Patient's Decision to Refuse Multiple Myeloma (MM) Treatment, and Its Impact on Outcomes

Vivek Kumar, MD, M.B.,B.S., Mays F Abdulazeez, MBBS, Srilekha Bodepudi, Suman Biswas, Vivek Roy, MD, Taimur Sher, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3494.
https://doi.org/10.1182/blood-2019-125888
Published: 2019
Journal Articles

What's in a Name? a Gender-Based Analysis of Speaker Introductions at the American Society of Hematology Annual Meeting

Urshila Durani, MDMPH, Narjust Duma, MD, Jessica A Slostad, MD, Christopher E. Wee, MD, Yael Kusne, MD PhD, Shruti Patel, MD, Carolina Bernabe, MD, Ana Velazquez, MD, Cynthia Brooke Woods, DO, Martina C. Murphy, MD, Miriam Knoll, MD, Shikha Jain, MD, Stephanie L. Graff, MD, Ariela L. Marshall, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3411.
https://doi.org/10.1182/blood-2019-131484
Published: 2019
Journal Articles

Health Care Costs Associated with Contemporary Chronic Myelogenous Leukemia (CML) Therapy Compared to Other Hematologic Malignancies (HEM)

Jennifer J. Wilkes, MDMSCE, Gary H. Lyman, MD MPH, David R Doody, MS, Shasank R Chennupati, PharmD, MPH, Laura Becker, MS, Pamela E Morin, Lena E. Winestone, MD MSHP, Henry (Joe) Henk, PhD, Eric J Chow, MD MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 4753.
https://doi.org/10.1182/blood-2019-124106
Published: 2019
Journal Articles

Analysis of Intestinal Microbiome in Multiple Myeloma Reveals Progressive Dysbiosis Compared to MGUS and Healthy Individuals

Crystal Antoine Pepeljugoski, MD, Gareth Morgan, MD PhD, Marc Braunstein, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3076.
https://doi.org/10.1182/blood-2019-130643
Published: 2019
Journal Articles

Up-Regulation of the mRNA Expression and Plasma Activity of PADI4in Sickle Cell Anemia during Acute Crisis

Bidossessi Wilfried Hounkpe, Francine Chenou, Igor de Farias Domingos, MSc, Evilazio Cunha Cardoso, Marcondes José de Vasconcelos Costa Sobreira, Aderson da Silva Araujo, MD PhD, Antonio Roberto Lucena-Araújo, PhD, Pedro Vieira da Silva Neto, Adriana Malheiro, PhD, Nelson Abrahim Fraiji, MD PhD, Fernando Ferreira Costa, MD PhD, Marcos André Cavalcanti Bezerra, PhD, Magnun Nueldo Nunes Santos, MSc, PhD, Erich V De Paula, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2257.
https://doi.org/10.1182/blood-2019-125630
Published: 2019
Journal Articles

Plasma Exchange in Thrombotic Microangiopathy: Is It Time Sensitive?

Sindhu Malapati, MD, Sunny R K Singh, MD, Rohit Kumar, MD, Jason Mouabbi, MD, Tarik Hadid, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2353.
https://doi.org/10.1182/blood-2019-129375
Published: 2019
Journal Articles

Trends in Early Mortality from Multiple Myeloma (MM): A Population-Based Analysis

Vivek Kumar, MD, M.B.,B.S., Mays F Abdulazeez, BMSC, Suman Biswas, MD, Sri Lekha Bodepudi, Vivek Roy, MD, Taimur Sher, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Salman Ahmed, MD, Prachi Jani, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 71.
https://doi.org/10.1182/blood-2019-124799
Published: 2019
Journal Articles

Alpine: Phase 3 Trial of Zanubrutinib (BGB-3111) Vs Ibrutinib in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Peter Hillmen, MD PhD, Jennifer R. Brown, MD PhD, John C. Byrd, MD, Barbara F. Eichhorst, MD, Nicole Lamanna, MD, Susan M. O'Brien, MD, Lugui Qiu, MD PhD, Tommi Salmi, MD, James Hilger, PhD, Jane Huang, MD, Constantine S. Tam, MBBS, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4307.
https://doi.org/10.1182/blood-2019-124213
Published: 2019
Journal Articles

A Phase 3 Trial Comparing the Efficacy and Safety of Acalabrutinib in Combination with Venetoclax with or without Obinutuzumab, Compared with Investigator's Choice of Chemoimmunotherapy in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) without Del(17p) or TP53 Mutation

Jennifer R Brown, MD PhD, Barbara F. Eichhorst, MD, Paolo Ghia, MD PhD, Arnon P. Kater, MD PhD, Jianyong Li, MD, Sudha Khurana, Mostafa Elhamy, Min Hui Wang, PhD, John F. Seymour, MBBS, PhD FRACP
Journal: Blood
Blood (2019) 134 (Supplement_1): 4318.
https://doi.org/10.1182/blood-2019-123057
Published: 2019
Journal Articles

First Review of Multiple Myeloma Patients in Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates

Mohamed Abu Haleeqa, MBBS, Fatima Alkaabi, MBBS, Raneem Janodi, MBBS, Emadullah Raidullah, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5587.
https://doi.org/10.1182/blood-2019-128769
Published: 2019
Journal Articles

A Population-Based Study of T/Myeloid Mixed Phenotype Acute Leukemia

Rebecca Wetzel, DO, Christin Destefano, MD, Daniel Brooks, PhD, Krista Shaw, MS III
Journal: Blood
Blood (2019) 134 (Supplement_1): 5090.
https://doi.org/10.1182/blood-2019-121646
Published: 2019
Journal Articles

Pediatric Acute Promyelocytic Leukemia in Brazil: Epidemiology, Molecular Features, and Importance of GST-Theta 1 in Chemotherapy Response and Outcome

Francianne G. Andrade, MSc, PhD, Suellen V. M. Feliciano, MSc, PhD, Ingrid Sardou-Cezar, Gisele D. Brisson, MSc, Filipe V. S. Bueno, MSc, Danielle T. Vianna, MD MSc, Eugênia Terra-Granado, MSc, PhD, Ilana Z. Renault, Marceli O. Santos, MSc, PhD, Elda P. Noronha, MSc, PhD, Joseph L. Wiemels, PhD, Maria S. Pombo-de-Oliveira, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5187.
https://doi.org/10.1182/blood-2019-131529
Published: 2019
Journal Articles

Hematological Profile in the Saudi Population: Reference Intervals By Gender, Age and Regions

Ahmed Alaskar, Hina Rehan, May Anne Mendoza, Aljowhara Alsahan, Anita Immanuel, BSc, Ayman Alhejazi, MD, Khadega Abuelgasim, Hind Salama, Moussab Damlaj, Giamal Gmati, Mohsen Alzahrani, Mushtaq Rather, Bader Alahmari, Areej Al Mugairi, Anwar Ahmed
Journal: Blood
Blood (2019) 134 (Supplement_1): 5804.
https://doi.org/10.1182/blood-2019-125264
Published: 2019
Journal Articles

Effects of Ramadan Fasting in Patients with Chronic Myeloid Leukemia in Chronic Phase

Mohamed A Yassin, MBBS, MSc, Rola S Ghasoub, BSC, Mahmood B Aldapt, MD, Mohammad Abdul-Jaber Abdulla, MD, Prem Chandra, PhD, Hawraa M Shwaylia, MD, Abdulqadir Jeprel Nashwan, BSN, MSN, Nancy Kassem, BSC, Susanna Jane Akiki, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5907.
https://doi.org/10.1182/blood-2019-121827
Published: 2019
Journal Articles

Understanding the Association between Transfusion Status (TS) and Overall Survival (OS), and Other Clinical Outcomes in Patients with Myelodysplastic Syndromes (MDS) from the Physicians' Perspective: A Pilot Survey

Shaloo Gupta, Zhiyi Li, Thomas Schroeder, MD, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Joana E. Matos, Alexandra Berk, Derek Tang, PhD BSPharm, Jay Grisolano
Journal: Blood
Blood (2019) 134 (Supplement_1): 5901.
https://doi.org/10.1182/blood-2019-122725
Published: 2019
Journal Articles

Bolus: Targeted Specialist Haematology Education

Sonia Thomas, Sarah Jordan, RN, MSc, Gavin Cooper, RN, BSc, Stephen D Rowley, RN, RSCN, BSc (Hons), MSc, Simon Clare, MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5863.
https://doi.org/10.1182/blood-2019-128397
Published: 2019